semaj83/ctmatch_classification huggingface dataset:
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Pneumococcal Disease Prevention recommended for pneumococcal vaccination according to age or medical comorbidity  already known to have received pneumococcal vaccine
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 65.0-999.0,  Influenza Ambulatory adult aged 65 and older Is in good health, as determined by vital signs (heart rate <100 bpm, blood pressure [systolic less than or equal to 160 mm Hg and diastolic less than or equal to 90 mm Hg] oral temperature < 100 degrees F), medical history to ensure stable medical condition, and a targeted physical examination based on medical history Able to understand and comply with planned study procedures Provides informed consent prior to any study procedures and is available for all study visits  Has a known allergy to eggs or other components of the vaccine or sensitivity to latex Is undergoing immunosuppression as a result of an underlying illness or treatment Has any malignancy (excluding nonmelanotic skin cancer) or lymphoproliferative disorder diagnosed or treated actively during the past 5 years Is using oral or parenteral steroids, high-dose inhaled steroids (>800 micrograms/day of beclomethasone dipropionate or equivalent) or other immunosuppressive or cytotoxic drugs Has a history of receiving immunoglobulin or other blood product within the 3 months prior to enrollment in this study Has received any other licensed vaccines within 2 weeks (for inactivated vaccines) or 4 weeks (for live vaccines) prior to enrollment in this study Has a history of alcohol abuse or drug abuse (including chronic pain medication) in the last 5 years Has an acute or chronic medical condition that, in the opinion of the investigator, would render vaccination unsafe or would interfere with the evaluation of responses. These conditions but are not limited to: history of significant renal impairment (dialysis and treatment for kidney disease, including diabetic and hypertensive kidney disease); subjects with diabetes mellitus, well-controlled with oral agents may enroll as long as there has been no dose adjustment within the past 6 months; insulin-dependent diabetes is excluded; cardiac insufficiency, if heart failure is present (New York Heart Association Functional Class III or IV); arteriosclerotic event during the 6 months prior to enrollment (e.g., history of myocardial infarction, stroke, recanalization of femoral arteries, or transient ischemic attack) Has a history of severe reactions following immunization with influenza virus vaccines Has an acute illness, including an oral temperature greater than 100.0 degrees F, within 1 week prior to vaccination
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 1.0-2.917,  Influenza Twelve to 35 months of age at enrollment Minimum weight of 8 kg In good health, as determined by parent/guardian verbal medical history and physical examination by clinical investigator Parent/guardian available by telephone for safety data collection through 6 months post-dose 2 Ability of parent/guardian to understand and comply with the requirements of the protocol Signed informed consent document and Health Insurance Portability and Accountability Act (HIPAA) authorization by the parent/guardian prior to performance of any study procedures  History of hypersensitivity to any component of LAIV or TIV, including egg or egg products History of hypersensitivity to gentamicin Known or suspected immune deficiency diseases or immunosuppressed or have altered or compromised immune status as a consequence of treatment with immunosuppressive therapies Known close contact with a severely immunocompromised person, such as someone currently in isolation secondary to a bone marrow transplantation (LAIV recipients should avoid close contact with severely immunocompromised individuals for at least 7 days after vaccination) History of chronic underlying medical conditions such as chronic disorders of the cardiovascular and pulmonary systems, chronic metabolic diseases (including diabetes), renal dysfunction, or hemoglobinopathies History of Guillain-Barré syndrome History of asthma or reactive airways disease Acute febrile (>99.6 degrees Fahrenheit axillary) and/or respiratory illness, within the 72 hours prior to enrollment Use of aspirin or aspirin containing products in the month prior to enrollment or anticipated use during the study Administration of any intranasal medication within 2 weeks prior to enrollment or expected receipt during this study
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 10.0-999.0,  Allergic Conjunctivitis history of ocular allergies and a positive skin test reaction to cat hair cat dander, grasses, ragweed, and/or trees within the past 24 months calculated best-corrected visual acuity of 0.6 logMar or better in each eye; - positive bilateral conjunctival allergy challenge reaction  narrow angle glaucoma clinically significant blepharitis, follicular conjunctivitis, iritis pterygium or diagnosis of dry eye ocular surgical intervention within 3 months history of refractive surgery within 6 months known history of retinal detachment, diabetic retinopathy, or progressive retinal disease presence of active ocular infection positive history of an ocular herpetic infection preauricular lymphadenopath manifest signs or symptoms of clinically active allergic conjunctivitis
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 50.0-999.0,  Young Healthy Adults Ventricular Dysfunction part I: 18 to 50-year-old patients undergoing surgical procedures under general anesthesia part II: 50-years-old patients or older with arterial hypertension under chronic antihypertensive medication subsequently undergoing surgical procedures under general anesthesia, EF >50%  part I: any cardiac or pulmonary disease, any medication with cardiovascular effects or side effects, body mass index > 30 kg/m2, esophageal reflux, emergency part II: History of myocardial infarction or coronary revascularization, severe lung disease, body mass index > 30 kg/m2, esophageal reflux, emergency
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 10.0-999.0,  Allergic Conjunctivitis history of ocular allergies and a positive skin test reaction to cat hair, cat dander, grasses, ragweed, and/or trees within the past 24 months; calculated best-corrected visual acuity of 0.6 logMar or better in each eye; positive bilateral conjunctival allergy challenge reaction -  narrow angle glaucoma, clinically significant blepharitis, follicular conjunctivitis, iritis, pterygium or diagnosis of dry eye; ocular surgical intervention within 3 months; history of refractive surgery within 6 months; known history of retinal detachment, diabetic retinopathy, or progressive retinal disease; presence of active ocular infection positive history of an ocular herpetic infection; preauricular lymphadenopath; manifest signs or symptoms of clinically active allergic conjunctivitis
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 18.0-49.0,  Influenza Subject is healthy, as determined by medical history and clinical assessment before entering the study Between the ages of 18 and 49 (greater than or equal to 18 and less than 50) Provides written informed consent Able to attend all scheduled visits and to comply with all trial procedures For a woman, menopausal or surgically sterile or negative serum/urine pregnancy test within 24 hours prior to the time of vaccination  Breast-feeding or pregnant History of receiving 2003-2004, 2004-2005 or 2005-2006 influenza vaccine Known allergy to eggs or other components of the vaccine (e.g., thimerosal) History of a severe reaction following influenza vaccination, systemic hypersensitivity to any of the vaccine components, or history of a life-threatening reaction to a vaccine containing the same substances History of Guillain-Barre Syndrome Immunosuppression as a result of underlying illness or treatment Use of oral steroids, parenteral steroids, or high-dose inhaled steroids (>800 mcg per day of beclomethasone dipropionate or equivalent) within 1 month prior to vaccination Use of other immunosuppressive or cytotoxic drugs or radiation therapy within the six months prior to vaccination Active neoplastic disease or history of any hematologic malignancy in the past 5 years (except localized skin or prostate cancer that is stable in the absence of therapy) Acute or chronic condition that (in the opinion of the Investigator) would render vaccination unsafe or would interfere with the evaluation of responses including, but not limited to the following: known chronic liver disease, significant renal disease, oxygen-dependent chronic lung disease, New York Heart Association Functional Class III or IV, unstable or progressive neurologic disorder, insulin-treated diabetes mellitus
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 0.0-999.0,  Menopause Hot Flashes Sleep Disorders Generally healthy, postmenopausal women who seek treatment for hot flushes Minimum of 7 moderate to severe hot flushes per day or 50 per week recorded for 7 consecutive days during screening Body Mass Index (BMI) less than or equal to 40 kg/m2 Other inclusions apply  Hypersensitivity to Venlafaxine History of seizure disorder History of myocardial infarction or unstable angina within 6 months Other exclusions apply
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 18.0-45.0,  Typhoid Fever To be eligible, volunteers must be 18 to 45 years old, who 1. are not participating in or plan to participate in another research protocol during the next three months; 2. have not been vaccinated against typhoid fever or had typhoid fever within the last 5 years; 3. are not regularly taking a prescription drug for chronic medical condition; 4. have no history of allergy to fruit or fruit pectin; 5. are not pregnant or intend to become pregnant during the study period of 6 months; 6. Whose HIV, HBsAg and HCV tests must be found negative and laboratory tests of liver function, blood chemistry, complete blood count and urine must show no clinically significant abnormality or pregnancy
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 18.0-64.0,  Influenza Able to understand and comply with all study procedures including availability for all study visits and follow up surveys within 6 months following study enrollment DEERS eligible beneficiaries eligible for influenza vaccination and able to give informed consent Age 18-49 Patients presenting to travel clinic with no  Household contacts and out-of-home caretakers of infants from 6-23 months of age Hospital and/or employees providing service to the public who are not eligible for the post-October 5th recommendations for priority immunization DOD employees eligible for influenza vaccination prior to October 5th but excluded in the post October 5th guidelines People living in dormitories or under other crowded conditions, to prevent outbreaks Ages 50-64 years of age who are not eligible for the post-October 5th recommendations for priority immunization and with no standard of care contraindications to vaccination Eligible in the Department of Defense for influenza vaccination all children aged < 18 years (includes children aged 6 months-18 years on chronic aspirin therapy) adults aged >65 years persons aged 2-64 years with underlying chronic medical conditions includes persons with chronic cardiac or pulmonary disease, diabetes mellitus, hemoglobinopathy, or immunosuppressive illness
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Hepatitis B Hepatitis A Subjects participating in this study should have received three-dose primary vaccination with combined hepatitis A/hepatitis B vaccine in the primary study Written informed consent will be obtained from each subject before the blood sampling visit of each year
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 1.0-999.0,  Influenza Avian Influenza Severe Influenza At least one of the following respiratory symptoms: cough, dyspnea, sore throat Evidence of severe influenza or avian influenza, as defined below Severe influenza infection 1. Need for hospitalization 2. One of the following: 1. New infiltrate on chest x-ray (or any infiltrate if no prior chest x-ray or not known) 2. Severe tachypnea (more information on this criterion can be found in the protocol) 3. Severe dyspnea 4. Arterial oxygen saturation of 92% or less on room air by trans-cutaneous method 3. Positive diagnostic testing for influenza, as defined by either rapid influenza antigen (Ag) positive (A or B) or qualitative reverse transcriptase-polymerase chain reaction (RT-PCR) positive for any influenza 4. Illness (defined by onset of fever, respiratory symptoms, or constitutional symptoms) began within 10 days before study enrollment Avian influenza infection 1. Nasal wash, nasopharyngeal aspirate, endotracheal aspirate, nasal swab, or throat swab that is RT-PCR positive influenza for H5 influenza 2. Illness (defined by onset of fever, respiratory symptoms, or constitutional symptoms) began within 14 days before study enrollment  Received more than 72 hours of oseltamivir (six doses) within 14 days Received oseltamivir at higher than standard doses within the last 14 days or during current acute illness, whichever is longer History of allergy or severe intolerance of oseltamivir, as determined by the investigator Alternate explanation for the clinical findings, as determined by the investigator and with the information immediately available Creatine clearance less than 10 ml/minute Pregnant or breastfeeding
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 60.0-999.0,  Influenza Influenza Vaccines Subjects who the investigator believes that they can and will comply with the requirements of the protocol A male or female aged over 60 years at the time of vaccination Written informed consent obtained from the subject  Use of any investigational or non-registered product (drug or vaccine) other than the study vaccine(s) within 30 days preceding the administration of the study vaccine, or planned use during the study period Participation in an earlier study with a candidate pandemic H9N2 vaccine Acute disease at the time of enrolment Acute clinically significant pulmonary, cardiovascular, hepatic or renal functional abnormality History of allergic disease or reactions likely to be exacerbated by any component of the vaccine Drug and/or alcohol dependency
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 18.0-65.0,  Breast Neoplasms Fibrocystic Disease of Breast Mammaplasty first visit to a Breast Disease Ambulance for consultation no pregnancy  no severe heart disease (EF > 40%) no therapy with digitalis no acute/chronic inflammatory disease (e.g. RA, M. Crohn) no dysfunction of the Hypothalamo-Pituitary-Adrenal system no severe mental disorder
Patient description: A 67-year-old healthy woman came to the clinic to have her flu shot in early October. She works at a rehab center and has no underlying disease. It is her first vaccination this year. she is menopausal and has 4 children. She does not some. She takes daily multivitamins and anti-hypertensive drugs. She exercises regularly for 30 minutes a day at least 5 days a week. She has no allergies to any food or drugs.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Influenza Working in the production of H5N1 vaccine at Aventis Pasteur facilities at Swiftwater, Pennsylvania. 2. Male or nonpregnant female (as indicated by a negative urine pregnancy test prior to each dose of vaccine), aged 18 years and older. 3. Women of childbearing potential who are at risk of becoming pregnant must agree to practice adequate contraception (ie, barrier method, abstinence, and licensed hormonal methods) for the entire study period. 4. Is in good health, as determined by vital signs (pulse, blood pressure, oral temperature), medical history, and a targeted physical examination based on medical history. 5. Able to understand and comply with planned study procedures. 6. Provides informed consent prior to any study procedures and is available for all study visits  Has a known allergy to eggs or other components of the vaccine. 2. Has a known allergy or sensitivity to latex (in the stopper). 3. Is breastfeeding. 4. Is undergoing immunosuppression as a result of an underlying illness or treatment. 5. Has an active neoplastic disease or a history of any hematologic malignancy. 6. Is using oral or parenteral steroids, high-dose inhaled steroids (>800 mcg/day of beclomethasone dipropionate or equivalent) or other immunosuppressive or cytotoxic drugs. 7. Has a history of receiving immunoglobulin or other blood product within the 3 months prior to enrollment in this study. 8. Has an acute illness, including an oral temperature greater than 100.4 degrees F, within 1 week of vaccination. 9. Received an experimental agent (vaccine, drug, biologic, device, blood product, or medication) within 1 month prior to enrollment in this study, or expects to receive an experimental agent during the 6-month study period. 10. Has any condition that would, in the opinion of the site investigator, place the subject at an unacceptable risk of injury or render the subject unable to meet the requirements of the protocol